SLQT · SelectQuote, Inc.
$0.65
-0.05 (-6.56%)
At close · Jul 24
Market Cap
$122.10M
Shares
176.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.69
Open$0.70
Day$0.67–0.78
52W$0.56–2.77
Avg vol 30d1.2M
Short int1.6M · 0.9% float · 1.4d
Short vol50%
Last earningsMay 5, 2026
DataMay 2020–Jul 2026
Filing10-Q · May 5
Up next
Next earnings call
Aug 3, 2026
Est · unconfirmed
· in 1 wks
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 5, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−41%
below
Price vs 50-day avg
−23%
below
RSI (14)
38
neutral
MACD trend
Negative
52-week position
6%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−27%
trailing
6-month return
−52%
trailing
YTD return
−51%
this year
Relative strength
−58%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
22 of 151 funds reported for Jun 30 · net +34.7K sh shares · +3 new
Insider flow
Distributing
Net -$4.1K over 90 days · 100% sells
Short interest
Rising
0.91% of float · ▲ +20.8% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
151 holders — mid 3-yr range
Squeeze score
35
low risk · 0–100
Fundamentals
Revenue growth
+15%
Y/Y
EPS growth
+105%
Y/Y
Free cash flow
$-13.9M
Valuation
P/E 13.9
below peers
Balance sheet
$352.7M
net debt
Quant / Vol
risk profile
Volatility
101%
annualized · 1-yr
Max drawdown
−78%
past year
ATR
10.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed May 5, 2026
Revenue
· Fiscal Year 2026
Initiated
$1.61B – $1.71B
prior FY $1.53B
midpoint +8.7% Y/Y
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−41%
Bearish
Price vs 50-day avg
−23%
Bearish
RSI (14)
38
Neutral
MACD trend
Negative
Bearish
52-week position
6%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
22 of 151 funds reported for Jun 30 · net +34.7K sh shares · +3 new
Insider flow
Distributing
Net -$4.1K over 90 days · 100% sells
Short interest
Rising
0.91% of float · ▲ +20.8% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
151 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 6%
52-wk high $3
vs 200-day avg -41%
vs 50-day avg -23%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Approved Medicare Advantage policies | 175,557 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Life Adjusted EBITDA non-GAAP | $6.1M | Three Months Ended March 31, 2026 | — |
|
|
|||
| Lifetime value of commissions per approved policy - Medicare Advantage | $904 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Prescriptions Per Day | 33,209 | Three Months Ended March 31, 2026 | — |
|
|
|||
| SelectRx members | 116,616 | as of March 31, 2026 | — |
| Submitted Medicare Advantage policies | 196,970 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Total approved policies | 196,709 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Total submitted policies | 221,882 | Three Months Ended March 31, 2026 | — |
|
|
|||
| Healthcare Services Adjusted EBITDA non-GAAP | $0.8M | Q2 FY2026 | — |
| Senior Adjusted EBITDA non-GAAP | $102.5M | Q2 FY2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Insurance Brokers — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SLQT
this stock
SelectQuote, Inc.
|
$122.10M | -50.9% | +31.3% | 13.9 | 0.9% |
|
MRSH
Marsh & Mclennan Companies, Inc.
|
$85.59B | -4.4% | +9.7% | 21.9 | 1.4% |
|
AON
Aon plc
|
$75.99B | +0.8% | -0.7% | 19.5 | 2.1% |
|
AJG
Arthur J. Gallagher & Co.
|
$62.22B | -6.1% | +16.6% | 39.2 | 3.1% |
|
WTW
Willis Towers Watson PLC
|
$27.72B | -12.0% | -2.2% | 17.2 | 3.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SLQT | -3.9% | -27.1% | -51.9% | -17.7% | -50.9% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -2.2% | -27.8% | -58.3% | -16.6% | -59.2% |
Key facts
CIK
1794783
CUSIP
816307300
13F (30d)
24 filings
24 filers
Visit website
Investor relations